AlzBiomarker
Control vs Alzheimer's Disease: GFAP (Plasma and Serum)
Meta-analysis of seven comparisons revealed that blood (plasma or serum) levels of the astrocytic marker glial fibrillary acid protein (GFAP) in control subjects are about half those of people with Alzheimer's disease (effect size = 0.519, p <0.0001).
Loading data...